Kaleido Biosciences Inc (KLDO)
0.00
USD |
OTCM |
Nov 13, 16:00
Kaleido Biosciences Shareholders Equity (Quarterly): 10.61M for Dec. 31, 2021
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | 10.61M |
| September 30, 2021 | 29.20M |
| June 30, 2021 | 50.27M |
| March 31, 2021 | 71.77M |
| December 31, 2020 | 20.50M |
| September 30, 2020 | 35.90M |
| June 30, 2020 | 51.32M |
| March 31, 2020 | 33.62M |
| Date | Value |
|---|---|
| December 31, 2019 | 48.88M |
| September 30, 2019 | 66.04M |
| June 30, 2019 | 84.63M |
| March 31, 2019 | 107.14M |
| December 31, 2018 | -96.24M |
| September 30, 2018 | -78.02M |
| December 31, 2017 | -43.68M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.61M
Minimum
Dec 2021
71.77M
Maximum
Mar 2021
39.12M
Average
35.90M
Median
Sep 2020
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
| Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 50.14M |
| Total Liabilities (Quarterly) | 39.53M |